Carbidopa

3 trials 1 recruiting NNeurology/Psychiatry

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

4 Sponsors

3 Countries

Phase II

Phase IV

Phase I (Other)

Phase II: 1 Phase IV: 1 Phase I (Other): 1

Indications tested

Neurodevelopmental disorder 1 Parkinson's disease 1

Sponsors using this IMP

Askbio Inc. 1 CCDRD Cooperative Clinical Drug Research and Development AG 1 Centre Hospitalier Universitaire De Nantes 1 PureIMS B.V. 1

All trials

3 total

A study to learn more about the long-term safety and efficacy of AB-1005 gene therapy in people with Parkinson’s disease or multiple system … Pending

2025-522653-19-00 Phase IV 1 country Askbio Inc.
Prospective pilot study of L-dopa treatment in patients with a neurodevelopmental disorder linked to a pathogenic variant of the CTNNB1 gene Recruiting

2024-514852-34-01 Phase II 1 country Centre Hospitalier Universitaire De Montpellier
A Pilot Open-label, Randomized, Crossover, Comparative Bioavailability Study of Levodopa Administered via Levodopa Cyclops™ (test product) R… Ended

2023-504687-42-00 Phase I (Other) 1 country CCDRD Cooperative Clinical Drug Research and Development AG; PureIMS B.V.

Showing 1–3 of 3 trials

← All drugs A–Z